Rhythm Pharmaceuticals Inc (RYTM)
38.11
-0.34
(-0.88%)
USD |
NASDAQ |
Apr 18, 16:00
38.10
-0.02
(-0.04%)
After-Hours: 20:00
Rhythm Pharmaceuticals Shareholders Equity (Quarterly): 169.76M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 169.76M |
September 30, 2023 | 197.47M |
June 30, 2023 | 182.28M |
March 31, 2023 | 219.76M |
December 31, 2022 | 264.26M |
September 30, 2022 | 281.20M |
June 30, 2022 | 195.63M |
March 31, 2022 | 235.77M |
December 31, 2021 | 284.15M |
September 30, 2021 | 322.26M |
June 30, 2021 | 351.69M |
March 31, 2021 | 380.95M |
December 31, 2020 | 166.53M |
September 30, 2020 | 196.94M |
Date | Value |
---|---|
June 30, 2020 | 225.75M |
March 31, 2020 | 253.10M |
December 31, 2019 | 281.02M |
September 30, 2019 | 149.12M |
June 30, 2019 | 181.47M |
March 31, 2019 | 220.49M |
December 31, 2018 | 246.26M |
September 30, 2018 | 269.64M |
June 30, 2018 | 284.32M |
March 31, 2018 | 133.66M |
December 31, 2017 | 144.79M |
September 30, 2017 | 29.09M |
June 30, 2017 | 35.77M |
December 31, 2016 | 7.297M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
149.12M
Minimum
Sep 2019
380.95M
Maximum
Mar 2021
238.90M
Average
225.75M
Median
Jun 2020
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 89.01B |
Insmed Inc | -331.92M |
Altimmune Inc | 194.10M |
Regeneron Pharmaceuticals Inc | 25.97B |
Viking Therapeutics Inc | 348.42M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 332.74M |
Total Liabilities (Quarterly) | 162.99M |
Current Ratio | 5.584 |